Peptide receptor radionuclide therapy (PRRNT) of neuroendocrine tumors: Relationship between tumor dose and molecular response as measured by somatostatin receptor PET/CT

被引：0
|
作者：
Kulkarni, Harshad [1 ,2 ]
Prasad, Vikas [1 ,2 ]
Schuchardt, Christiane [1 ,2 ]
Zachert, Carolin [1 ,2 ]
Baum, Richard [1 ,2 ]
机构：
[1] Zent Klin Bad Berka, Nucl Med, Bad Berka, Germany
[2] Zent Klin Bad Berka, Ctr PET CT, Bad Berka, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
301
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Safety and efficacy of peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumor patients having single kidney or nonfunctional kidney
    Prasad, Vikas
    Kulkarni, Harshad
    Zachert, Carolin
    Hoersch, Dieter
    Baum, Richard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [22] Optimized segmentation of neuroendocrine tumor lesions on somatostatin receptor PET/CT imaging for therapy response assessment
    Chaban, A.
    Brosch-Lenz, J.
    Song, Y.
    Dinkel, V.
    Bodei, L.
    Weber, W.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S134 - S135
  • [23] Molecular Imaging Tumor Volume of Somatostatin Receptor (MITVSSR) on 68Ga-DOTATATE PET/CT, dosimetry and predictors of overall survival and response in unresectable neuroendocrine neoplasms treated with Peptide Receptor Radionuclide Therapy (PRRT)
    Alipour, R.
    Jackson, P.
    Callahan, J.
    Bressel, M.
    Hogg, A.
    Hicks, R.
    Kong, G.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 135 - 135
  • [24] Joint Guidance on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
    Delbeke, Dominique
    Graham, Michael M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) : 663 - 663
  • [25] Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors
    Lo Russo, Giuseppe
    Pusceddu, Sara
    Prinzi, Natalie
    Imbimbo, Martina
    Proto, Claudia
    Signorelli, Diego
    Vitali, Milena
    Ganzinelli, Monica
    Maccauro, Marco
    Buzzoni, Roberto
    Seregni, Ettore
    de Braud, Filippo
    Garassino, Marina Chiara
    [J]. TUMOR BIOLOGY, 2016, 37 (10) : 12991 - 13003
  • [26] Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Jong, Marion
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    [J]. NEUROENDOCRINOLOGY, 2013, 97 (01) : 74 - 85
  • [27] Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    de Herder, Wouter W.
    van Eijck, Casper H. J.
    Kam, Boen L.
    van Essen, Martijn
    Teunissen, Jaap J. M.
    Krenning, Eric P.
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2010, 40 (02) : 78 - 88
  • [28] Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors
    Abou Jokh Casas, E.
    Pombo Pasin, M. D.
    Pubul Nunez, V.
    Garrido Pumar, M.
    Blanco Freire, M. N.
    Cabezas, J.
    Cameselle, J.
    Berrios, M.
    Argibay, S.
    Ruibal Morell, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S597 - S598
  • [29] Peptide Receptor Radionuclide Therapy (PRRNT) in Patients with Metastasized Neuroendocrine Tumor Having Single or Non-Functional Kidney - Is It Safe?
    Prasad, V
    Hoersch, D.
    Zachert, C.
    Baum, R. P.
    [J]. NEUROENDOCRINOLOGY, 2011, 94 : 40 - 41
  • [30] 177Lu-Dotatate Peptide Receptor Radionuclide Therapy Dose Response in Small Intestinal Neuroendocrine Tumors
    Jahn, U. M. M.
    Ilan, E.
    Sandstrom, M.
    Bamerny, M.
    Garske-Roman, U.
    Lubberink, M.
    Sundin, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S157 - S158
12345